@ARTICLE{
author={Lentz Steven R,Janic Dragana M,Kavakli Kaan,Miljic Predrag S,Oldenburg Johannes,Ozelo Margareth Castro,Santagostino Elena,Suzuki Takashi,Zupancic-Salek Silva,Korsholm Lars,Matytsina Irina,Tiede Andreas},
year={2018},
title={Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial},
journal={HAEMOPHILIA},
volume={24},
number={6},
pages={E391-E394},
document_type={Article},
} 

@ARTICLE{
author={Auerswald Guenter,Zupancic-Salek Silva,Benson Gary,Elezovic Ivo V,Lambert Thierry,Morfini Massimo,Pasi John,Remor Eduardo,Santagostino Elena,Salaj Peter,Ljung Rolf},
year={2012},
title={Beyond patient benefit: clinical development in hemophilia},
journal={HEMATOLOGY},
volume={17},
number={1},
pages={1-8},
document_type={Review},
} 

@ARTICLE{
author={Benson Gary,Auerswald Guenter,Elezovic Ivo V,Lambert Thierry,Ljung Rolf,Morfini Massimo,Remor Eduardo,Zupancic-Salek Silva},
year={2012},
title={Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice},
journal={EUROPEAN JOURNAL OF HAEMATOLOGY},
volume={88},
number={5},
pages={371-379},
document_type={Review},
}